Page 4 - Transitional Coverage News Today

Operator: Good afternoon, and welcome to the Cytosorbents Fourth Quarter and Full Year 2022 Financial and Operating Results Conference Call. At this time, all participants are in a listen-only mode.

On February 13-14, 2023, the Centers for Medicare & Medicaid Services (CMS) convened a virtual panel of the Medicare Evidence Development & Coverage…

On February 13-14, 2023, the Centers for Medicare & Medicaid Services (CMS) convened a virtual panel of the Medicare Evidence Development & Coverage Advisory Committee (MEDCAC) to...

The five-person expert panel had several recommendations for the Center for Tobacco Products.

President Joe Biden’s positive tests following a five-day course of Paxlovid have raised questions about the frequency of the rebound phenomenon.

The Biden administration announced plans to propose a rule that would cap the amount of nicotine in finished tobacco products.

(2022-05-26 | NDAQ:RWLK) ReWalk Robotics Files Revised Preliminary Proxy Statement and Issues Letter to Shareholders

        Highlights the Company’s Recent Progress and Momentum Towards Value-Enhancing Commercialization and Reimbursement Notes that Current Board and...

Helius Medical Technologies, Inc. (NASDAQ:NASDAQ:HSDT) Q1 2022 Earnings Conference Call May 12, 2022 9:00 AM ET Company Participants Judy DiClemente – In-Site Communications, Inc.

Our analysis demonstrates that CMS’s coverage processes for breakthrough devices demonstrate product class and disease state disparities. These disparities contradict mental health parity statute, CMS Administrator Brooks-LaSure’s focus on equity, and President Biden’s charge to improve brain health.